Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 28.3 USD -0.63% Market Closed
Market Cap: 874.8m USD

Fulgent Genetics Inc
Total Other Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Fulgent Genetics Inc
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Fulgent Genetics Inc
NASDAQ:FLGT
Total Other Income
$116k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Total Other Income
$14m
CAGR 3-Years
N/A
CAGR 5-Years
-30%
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Total Other Income
$108m
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Total Other Income
$13.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guardant Health Inc
NASDAQ:GH
Total Other Income
$77.4m
CAGR 3-Years
N/A
CAGR 5-Years
-20%
CAGR 10-Years
N/A
No Stocks Found

Fulgent Genetics Inc
Glance View

Market Cap
873.2m USD
Industry
Health Care

Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. The company is headquartered in Temple City, California and currently employs 645 full-time employees. The company went IPO on 2016-09-28. The firm develops a technology platform, which offers a test menu. The company performs full-gene sequencing with deletion/duplication analysis in single-gene tests; pre-established, multi-gene, disease-specific panels; and customized panels. Its test offerings also include Solid Tumor Molecular Profiling for somatic cancer testing, Rapid Whole Genome testing developed for children in neonatal intensive care units or pediatric intensive care units its Newborn Genetic Analysis panel, and a single front-line test designed to comprehensively detect ataxia-related variants. The company also offers certain research service tests, which are ordered by research institutions and other similar institutional customers.

FLGT Intrinsic Value
16.37 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Fulgent Genetics Inc's Total Other Income?
Total Other Income
116k USD

Based on the financial report for Sep 30, 2025, Fulgent Genetics Inc's Total Other Income amounts to 116k USD.

What is Fulgent Genetics Inc's Total Other Income growth rate?
Total Other Income CAGR 1Y
-79%

Over the last year, the Total Other Income growth was -79%.

Back to Top